低的脑前性尿素水平预测急性肺栓塞的良性临床结果
Nils Kucher1, Gert Printzen, Tanja Doernhoefer
1Swiss Cardiovascular Center, Cardiology, University Hospital, Bern, Switzerland. nkucher@partners.org
Circulation
|April 2, 2003
概括
低的脑前性尿素 (proBNP) 水平有效预测急性肺栓塞 (PE) 患者的医院治疗过程有利. 低于500 pg/mL的proBNP确定了适合短期住院或门诊治疗的个人.
科学领域:
- 心脏病学 心脏病学
- 肺部医学 肺部医学
- 生物标志物研究 生物标志物研究
背景情况:
- 亲脑尿素 (proBNP) 对急性肺栓塞 (PE) 的临床结果的预测价值尚未先前确定.
- 急性PE是致病率和死亡率的重要原因,需要准确的预后工具.
研究的目的:
- 研究proBNP在预测急性肺栓塞 (PE) 诊断患者的临床结果中的作用.
- 确定低proBNP水平是否可以识别低不良事件风险的患者,从而减少住院时间.
主要方法:
- 在入院4小时内测量了73名急性PE患者的ProBNP水平.
- 临床不良结果被定义为在医院死亡或需要进行心肺复苏,机械呼吸,压力器,血栓溶解或栓塞切除等干预措施.
- 统计分析包括对不同组的proBNP水平进行比较,并在对临床因素进行调整后评估其独立的预测值.
主要成果:
- 与良性结局 (121 pg/mL;P<0.0001) 患者相比,具有不良临床结局的患者的中位数proBNP水平 (4250 pg/mL) 显著更高.
- 低于500 pg/mL的proBNP水平显示了对不良临床结果的97%负预测值.
- 即使在调整了PE严重程度,托波宁T,年龄,性别和心力衰竭史之后,ProBNP仍然是不良结果的独立预测因素 (OR 14.6,P=0.02).
结论:
- 在被诊断为急性PE的患者中,低proBNP水平表明无事件的住院过程.
- <500 pg/mL的proBNP值可以识别急性PE患者适合缩短住院或门诊管理,优化资源利用.
相关概念视频
Urodynamic Studies: Uroflowmetry
Uroflowmetry is a non-invasive urodynamic test designed to measure various aspects of urination, including volume, flow rate, and the time to void. This test is crucial for diagnosing and assessing conditions such as bladder outlet obstruction, bladder dysfunction, incomplete bladder emptying, incontinence, and urinary tract blockages caused by benign prostatic hyperplasia (BPH) and urethral strictures.Pre-Test Instructions:Before a uroflowmetry test, patients are typically advised to drink...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Pulmonary Edema II: Pathophysiology
Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...


